Now that prominent compliance deadlines are nearing in the US, Saudi Arabia and Russia and with the Falsified Medicines Directive (FMD) now in force in Europe, what is going on around the world with serialisation? Allan Bowyer provides a rundown of current events and shares insights into the challenges businesses…
List view / Grid view
Filter the results
Researchers have discovered that pharma companies see the most need to invest in data protection and cybersecurity over other technologies.
Researchers have found that 33 percent of companies in the life sciences sector experienced an information leak within the last year.
Researchers have created an AI model that analyses the citations of studies, predicting their potential for eventual clinical application.
A new initiative has already collaboratively reviewed applications for two oncology drugs, allowing for simultaneous decisions in three countries.
The seven centres will aid disease research and clinical development, improving access to patient data for studies.
New article says that to take full advantage of deep-learning solutions in healthcare, the US and China should collaborate, not compete.
The successful pilot programme could represent an important step forward in biopharmaceutical supply chain innovation.
New digital design and manufacturing techniques offer pharmaceutical manufacturers the possibility of a systems-based, digital approach to substantially streamline their design, development and manufacturing processes. The ADDoPT collaborative consortium has been working to explore how emerging process understanding and predictive models can be applied and embedded within industrial workflows to…
Having a holistic data infrastructure in place can not only save time by providing key real-time information and money through readily-accessible, enterprise-wide intelligence, it can also ensure stress-free operations.
New supercomputing centres have been selected to support Europe's researchers, industry and businesses to design medicines.
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.